Farallon Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$317M |
| 2 |
Salesforce
CRM
|
+$270M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$259M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$221M |
| 5 |
PPLI
People Inc
PPLI
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.55B |
| 2 |
BRMK
Broadmark Realty Capital Inc. Common Stock
BRMK
|
+$754M |
| 3 |
AABA
Altaba Inc
AABA
|
+$666M |
| 4 |
Alibaba
BABA
|
+$196M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.48% |
| 2 | Communication Services | 11.12% |
| 3 | Technology | 9.77% |
| 4 | Industrials | 5.05% |
| 5 | Financials | 3.99% |
Similar funds
Farallon Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Farallon Capital Management held 132 positions worth $14.8B, up 12% from $13.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Farallon Capital Management withdrew a net $1.22B in Q4 2019, closing 16 positions and reducing 29 holdings. Its most notable exit was Celgene Corp, an estimated $1.55B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 40% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Farallon Capital Management opened a new position in Salesforce worth $281M.
- Farallon Capital Management's largest Q4 2019 buy was Salesforce: 1,724,880 shares worth $281M.
- Farallon Capital Management added most to Allergan plc in Q4 2019, an estimated $317M increase.
- Farallon Capital Management's biggest Q4 2019 reduction was Broadmark Realty Capital Inc. Common Stock, cutting an estimated $754M.
- Farallon Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.55B.
- Farallon Capital Management's ten largest holdings make up 44% of its $14.8B portfolio in Q4 2019.
- Farallon Capital Management opened 32 new positions and closed 16 in Q4 2019.
- Farallon Capital Management's portfolio value rose 12% quarter-over-quarter to $14.8B.
Based on Farallon Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.